This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting neurological and psychiatric disorders, particularly those involving dopamine and serotonin receptors. Its structural properties make it valuable for creating compounds with potential therapeutic effects in treating conditions such as schizophrenia, depression, and anxiety. Additionally, it is used in research settings to study receptor interactions and develop novel treatments for central nervous system disorders. Its hydrochloride form enhances stability and solubility, making it suitable for formulation and experimental purposes.